comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP- 1 Receptor Agonists in Type 2 Diabetes Improved Heart and Kidney Outcomes

The medication is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week

The observed incidence of antibody positivity in an assay is highly dependent on several factors including assay sensitivity and specificity, methodology, sample handling, timing of sample collection, concomitant medication and underlying disease

Here's the incremental weight loss per dose escalation from STEP-1 data: The curve flattens as you approach 2.4 mg

No clinical trials have studied Zepbound use in breastfeeding individuals yet

Dr Levy said this increases the risk of contamination and sterilization issues and warned that Wegovy needs to be taken with the oversight of a medical professional